GYEMSZI - MOB

European Journal of Microbiology and Immunology - Kapcsolódó tételek

351.			Seroprevalence of Chlamydophila psittaci among employees of two German duck farms
352.			Sexually Transmitted Infections in Soldiers - A Cross-Sectional Assessment in German Paratroopers and Navy Soldiers and a Literature Review
353.			SHP2-independent tyrosine dephosphorylation of cortactin and vinculin during infection with Helicobacter pylori
354.			Small intestinal pro-inflammatory immune responses following Campylobacter jejuni infection of secondary abiotic IL-10-/- mice lacking nucleotide-oligomerization-domain-2
355.			So close and yet so far - molecular microbiology of Campylobacter fetus subspecies
356.			Spatial and temporal dynamics of the prevalence of resistance genes and gastrointestinal pathogens in stool samples of German deployment returnees
357.			Spectrum of viral infections in patients with cystic fibrosis
358.			Spinal cord pathology in chronic experimental Toxoplasma gondii infection
359.			Staphylococcus aureus: Antimicrobial resistance, quorum sensing, and antibiofilm approaches
360.			Stillbirth history and Toxoplasma gondii infection in women attending public health centers in a northern Mexican city
361.			Structural biology of Nipah virus G and F glycoproteins: Insights into therapeutic and vaccine development
362.			Surveillance of enteropathogenic bacteria, protozoa and helminths in travellers returning from the tropics
363.			Survey of extra-intestinal immune responses in asymptomatic long-term Campylobacter jejuni-infected mice
364.			Sustained TL1A (TNFSF15) expression on both lymphoid and myeloid cells leads to mild spontaneous intestinal inflammation and fibrosis
365.			Synergistic Antimicrobial Effects of Cefabronchin
366.			The synthetic hydroxyproline-containing collagen analogue (Gly-Pro-Hyp)10 ameliorates acute DSS colitis
367.			The synthetic hydroxyproline-containing collagen analogue (Gly-Pro-Hyp)10 promotes enzymatic activity of matrixmetalloproteinase-2 in vitro
368.			Taking stock of infections and antibiotic resistance in the elderly and long-term care facilities: A survey of existingand upcoming challenges
369.			Targeting antigens to DEC-205 on dendritic cells induces immune protection in experimental colitis in mice
370.			Tattoos causing local and even generalized lymphadenopathies including sarcoidosis
371.			TFF Peptides Play a Role in the Immune Response Following Oral Infection of Mice with Toxoplasma gondii
372.			Therapeutic effects of oral benzoic acid application during acute murine campylobacteriosis
373.			Tim-3 is differently expressed in genetically susceptible C57BL/6 and resistant BALB/c mice during oral infection with Toxoplasma gondii
374.			Tissue-specific induction of CCR6 and Nrp1 during early CD4+ T cell differentiation
375.			Toll-like receptor-4 dependent inflammatory responses following intestinal colonization of secondary abiotic IL10-deficient mice with multidrug-resistant Pseudomonas aeruginosa
376.			Toll-like receptor-4 dependent intestinal gene expression during Arcobacter butzleri infection of gnotobiotic IL-10 deficient mice
377.			Toll-like receptor-4 dependent small intestinal immune responses following murine Arcobacter butzleri infection
378.			Toll-like receptor-4 is essential for Arcobacter butzleri-induced colonic and systemic immune responses in gnotobiotic IL-10-/- mice
379.			Topical microemulsion with phenolic compounds from Libidibia ferrea (Fabaceae): An alternative treatment for cutaneous leishmaniasis
380.			Toxoplasma gondii exposure and neurological disorders: An age- and gender-matched case-control pilot study
381.			Toxoplasma Gondii Infection and a History of Surgery: A Case Control Seroprevalence Study
382.			Toxoplasma Gondii Infection and Depression: A Case-Control Seroprevalence Study
383.			Toxoplasma gondii infection and multiple sclerosis: An age- and a gender-matched case-control seroprevalence study
384.			Toxoplasma gondii infection of chicken embryos causes retinal changes and modulates HSP90B1 gene expression: A promising ocular toxoplasmosis model
385.			Toxoplasma gondii infection of the central nervous system and suicide: A case-control study of decedents
386.			Toxoplasma gondii seroprevalence and risk factors of cats in the Budapest area
387.			Tracheoesophageal fistula due to Candida and Actinomyces co-infection: A case report and comprehensive review of the literature
388.			Treatment with interleukin-18 binding protein ameliorates Toxoplasma gondii-induced small intestinal pathology that is induced by bone marrow cell-derived interleukin-18
389.			Trichomonas vaginalis Detection in Female Specimens with cobasW TV/MG for use on the cobasW 6800/8800 Systems
390.			True facets of TB diagnosis in 2012: Hypes and realities
391.			Tuberculosis challenges: Resistance, co-infection, diagnosis, and treatment
392.			Tuberculosis in adolescents and young patients in high prevalence region
393.			Tuberculosis surveillance and control in Germany : an application of the Berlin Declaration Monitoring and Evaluation Framework
394.			Usage of murine T-cell hybridoma cells as responder cells reveals interference of Helicobacter pylori with human dendritic cell-mediated antigen presentation
395.			Validation of the Cepheid Xpert(R) Xpress SARS-CoV-2 using upper and lower respiratory tract specimens
396.			Very low prevalence of Mansonella perstans-specific cell-free DNA in serum samples of Ghanaian HIV patients
397.			Virulence genes in a probiotic E. coli product with a recorded long history of safe use
398.			Vitamin E as promising adjunct treatment option in the combat of infectious diseases caused by bacterial including multi-drug resistant pathogens - Results from a comprehensive literature survey
399.			What you eat is what you get: novel Campylobacter models in the quadrangle relationship between nutrition, obesity, microbiota and susceptibility to infection
400.			Worldwide Protein Data Bank (wwPDB): A virtual treasure for research in biotechnology

Mind kijelölve: